218 related articles for article (PubMed ID: 20022991)
41. Kallmann syndrome.
Dodé C; Hardelin JP
Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
[TBL] [Abstract][Full Text] [Related]
42. Variants in congenital hypogonadotrophic hypogonadism genes identified in an Indonesian cohort of 46,XY under-virilised boys.
Ayers KL; Bouty A; Robevska G; van den Bergen JA; Juniarto AZ; Listyasari NA; Sinclair AH; Faradz SM
Hum Genomics; 2017 Feb; 11(1):1. PubMed ID: 28209183
[TBL] [Abstract][Full Text] [Related]
43. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
Kim SH; Hu Y; Cadman S; Bouloux P
J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
[TBL] [Abstract][Full Text] [Related]
44. Gene-gene interactions and risk of recurrent miscarriages in carriers of endocrine gland-derived vascular endothelial growth factor and prokineticin receptor polymorphisms.
Su MT; Lin SH; Chen YC; Kuo PL
Fertil Steril; 2014 Oct; 102(4):1071-1077.e3. PubMed ID: 25064403
[TBL] [Abstract][Full Text] [Related]
45. Functional analysis of the distal region of the third intracellular loop of PROKR2.
Zhou XT; Chen DN; Xie ZQ; Peng Z; Xia KD; Liu HD; Liu W; Su B; Li JD
Biochem Biophys Res Commun; 2013 Sep; 439(1):12-7. PubMed ID: 23969157
[TBL] [Abstract][Full Text] [Related]
46. Sexually dimorphic distribution of Prokr2 neurons revealed by the Prokr2-Cre mouse model.
Mohsen Z; Sim H; Garcia-Galiano D; Han X; Bellefontaine N; Saunders TL; Elias CF
Brain Struct Funct; 2017 Dec; 222(9):4111-4129. PubMed ID: 28616754
[TBL] [Abstract][Full Text] [Related]
47. Correlation between Pituitary Stalk Interruption Syndrome and Prokineticin Receptor 2 and Prokineticin 2 Mutations.
Han BY; Li LL; Wang CZ; Guo QH; Lv ZH; Mu YM; Dou JT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Feb; 38(1):37-41. PubMed ID: 26956854
[TBL] [Abstract][Full Text] [Related]
48. Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism.
Wang Y; Gong C; Qin M; Liu Y; Tian Y
Clin Endocrinol (Oxf); 2017 Dec; 87(6):757-766. PubMed ID: 28833369
[TBL] [Abstract][Full Text] [Related]
49. The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome.
Bergman JE; de Ronde W; Jongmans MC; Wolffenbuttel BH; Drop SL; Hermus A; Bocca G; Hoefsloot LH; van Ravenswaaij-Arts CM
J Clin Endocrinol Metab; 2012 May; 97(5):E858-62. PubMed ID: 22399515
[TBL] [Abstract][Full Text] [Related]
50. Additional mutation in
Ichioka K; Yoshikawa T; Kimura H; Saito R
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272512
[TBL] [Abstract][Full Text] [Related]
51. Triallelic digenic mutation in the prokineticin 2 and GNRH receptor genes in two brothers with normosmic congenital hypogonadotropic hypogonadism.
Méndez JP; Zenteno JC; Coronel A; Soriano-Ursúa MA; Valencia-Villalvazo EY; Soderlund D; Coral-Vázquez RM; Canto P
Endocr Res; 2015; 40(3):166-71. PubMed ID: 25531638
[TBL] [Abstract][Full Text] [Related]
52. Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport.
Watson RP; Lilley E; Panesar M; Bhalay G; Langridge S; Tian SS; McClenaghan C; Ropenga A; Zeng F; Nash MS
Neurogastroenterol Motil; 2012 Jan; 24(1):65-75, e12. PubMed ID: 22050240
[TBL] [Abstract][Full Text] [Related]
53. Comparison of Clinical Characteristics and Spermatogenesis in CHH Patients Caused by PROKR2 and FGFR1 Mutations.
Li S; Zhao Y; Nie M; Yang Y; Hao M; Mao J; Wu X
Reprod Sci; 2021 Nov; 28(11):3219-3227. PubMed ID: 33983622
[TBL] [Abstract][Full Text] [Related]
54. Absence of central circadian pacemaker abnormalities in humans with loss of function mutation in prokineticin 2.
Balasubramanian R; Cohen DA; Klerman EB; Pignatelli D; Hall JE; Dwyer AA; Czeisler CA; Pitteloud N; Crowley WF
J Clin Endocrinol Metab; 2014 Mar; 99(3):E561-6. PubMed ID: 24423319
[TBL] [Abstract][Full Text] [Related]
55. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency.
Sykiotis GP; Plummer L; Hughes VA; Au M; Durrani S; Nayak-Young S; Dwyer AA; Quinton R; Hall JE; Gusella JF; Seminara SB; Crowley WF; Pitteloud N
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15140-4. PubMed ID: 20696889
[TBL] [Abstract][Full Text] [Related]
56. Light-Dependent Regulation of Sleep and Wake States by Prokineticin 2 in Zebrafish.
Chen S; Reichert S; Singh C; Oikonomou G; Rihel J; Prober DA
Neuron; 2017 Jul; 95(1):153-168.e6. PubMed ID: 28648499
[TBL] [Abstract][Full Text] [Related]
57. Identification of MMACHC and PROKR2 mutations causing coexistent cobalamin C disease and Kallmann syndrome in a young woman.
Yuan H; Deng S; Gao W; Li H; Yuan M
Metab Brain Dis; 2021 Mar; 36(3):447-452. PubMed ID: 33411215
[TBL] [Abstract][Full Text] [Related]
58. The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.
Marcos S; Sarfati J; Leroy C; Fouveaut C; Parent P; Metz C; Wolczynski S; Gérard M; Bieth E; Kurtz F; Verier-Mine O; Perrin L; Archambeaud F; Cabrol S; Rodien P; Hove H; Prescott T; Lacombe D; Christin-Maitre S; Touraine P; Hieronimus S; Dewailly D; Young J; Pugeat M; Hardelin JP; Dodé C
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2138-43. PubMed ID: 25077900
[TBL] [Abstract][Full Text] [Related]
59. Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2.
Matsumoto S; Yamazaki C; Masumoto KH; Nagano M; Naito M; Soga T; Hiyama H; Matsumoto M; Takasaki J; Kamohara M; Matsuo A; Ishii H; Kobori M; Katoh M; Matsushime H; Furuichi K; Shigeyoshi Y
Proc Natl Acad Sci U S A; 2006 Mar; 103(11):4140-5. PubMed ID: 16537498
[TBL] [Abstract][Full Text] [Related]
60. Evidence that FGFR1 loss-of-function mutations may cause variable skeletal malformations in patients with Kallmann syndrome.
Jarzabek K; Wolczynski S; Lesniewicz R; Plessis G; Kottler ML
Adv Med Sci; 2012; 57(2):314-21. PubMed ID: 23154428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
